BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xu L, Chen L, Zhang W. Neoadjuvant treatment strategies for hepatocellular carcinoma. World J Gastrointest Surg 2021; 13(12): 1550-1566 [PMID: 35070063 DOI: 10.4240/wjgs.v13.i12.1550]
URL: https://www.wjgnet.com/2307-8960/full/v13/i12/1550.htm
Number Citing Articles
1
Deniz Can Guven, Hasan Cagri Yildirim, Elvin Chalabiyev, Fatih Kus, Feride Yilmaz, Serkan Yasar, Arif Akyildiz, Burak Yasin Aktas, Suayib Yalcin, Omer Dizdar. Emerging treatment strategies in hepatobiliary cancerExpert Review of Anticancer Therapy 2023; 23(3): 243 doi: 10.1080/14737140.2023.2183844
2
Rubén Caiña Ruiz, Enrique Toledo Martínez, Edward Joseph Anderson, Víctor Valbuena Jabares, Roberto Fernández Santiago, Federico Castillo, Juan Echeverri, Mar Achalandabaso, Francisco José González Sánchez, Emilio Fábrega, Antonio Cuadrado, José Ignacio Fortea, Javier Crespo, Juan Carlos Rodríguez Sanjuán. Effect of Bridging Therapy on Survival in Hepatocellular Carcinoma Patients Who Receive Liver TransplantsTransplantation Proceedings 2022; 54(9): 2528 doi: 10.1016/j.transproceed.2022.09.007
3
Kelly M. Mahuron, Gagandeep Singh. Defining a New Classification System for the Surgical Management of Neuroendocrine Tumor Liver MetastasesJournal of Clinical Medicine 2023; 12(7): 2456 doi: 10.3390/jcm12072456
4
Kaihua Tang, Xiaoting Li, Jianwen Mo, Yixuan Chen, Chengyu Huang, Ting Li, Tianjian Luo, Zhijian Zhong, Yongqiang Jiang, Dengfeng Yang, Weiliang Mo. CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinomaScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-34261-1